TY  - GEN
AU  - Sato,Tomoo
AU  - Coler-Reilly,Ariella L G
AU  - Yagishita,Naoko
AU  - Araya,Natsumi
AU  - Inoue,Eisuke
AU  - Furuta,Rie
AU  - Watanabe,Toshiki
AU  - Uchimaru,Kaoru
AU  - Matsuoka,Masao
AU  - Matsumoto,Naoki
AU  - Hasegawa,Yasuhiro
AU  - Yamano,Yoshihisa
TI  - Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy
SN  - 1533-4406
PY  - 2018///0214
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antineoplastic Agents
KW  - Area Under Curve
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Exanthema
KW  - chemically induced
KW  - Female
KW  - Human T-lymphotropic virus 1
KW  - isolation & purification
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Paraparesis, Tropical Spastic
KW  - drug therapy
KW  - Receptors, CCR4
KW  - antagonists & inhibitors
KW  - T-Lymphocytes
KW  - immunology
KW  - Viral Load
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1056/NEJMoa1704827
ER  -